Company intelligence / Profile preview

Strauss Interests

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Strauss Interests is a Dallas-based private investment firm and family office led by Richard Strauss. The firm specializes in private equity and real estate investments, with a significant strategic focus on the life sciences and biotechnology sectors. Strauss Interests is notably recognized for its role as a founding investor and strategic partner in several high-profile biotech companies, including AveXis (acquired by Novartis) and Taysha Gene Therapies. The firm provides capital and strategic guidance to early-stage healthcare companies, particularly those focused on gene therapy and rare diseases.

Industry: Investors

Partnerships

AveXisTaysha Gene Therapies

Beyond the preview

Go deeper on Strauss Interests.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strauss Interests.

Explore the full profile